Vulnerability · Published Oct 20, 2026 · Assigned by oracle

CVE-2026-101451

High 8.7

In plain English

A high-severity cross-site request forgery in Siebel Life Sciences from Oracle Corporation. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.2% (higher than 5% of all known vulnerabilities).

Severity (CVSS 3.1)8.7High

Exploit odds (30 days)0.2%top 95.1% of all CVEs

Exploited in the wildNo reportsCISA SSVC: none

Attack toolingNoneno public tooling known

Official description

Vulnerability in the Siebel Life Sciences product of Oracle Siebel CRM (component: Web UI). Supported versions that are affected are 17.0-26.9. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Siebel Life Sciences. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Siebel Life Sciences, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Siebel Life Sciences accessible data as well as unauthorized access to critical data or complete access to all Siebel Life Sciences accessible data. CVSS 3.1 Base Score 8.7 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N).

Affected products (as reported)

Vendor	Product	Versions
Oracle Corporation	Siebel Life Sciences	17.0 – through 26.9

Weakness: CWE-352, CWE-284 · Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N

References

Oracle Advisory vendor-advisory